News

High Income Securities Fund Reveals Upcoming Monthly Payouts

High Income Securities Fund Reveals Upcoming Monthly Payouts

Overview of the High Income Securities Fund

The High Income Securities Fund (NYSE: PCF) has announced a series of monthly distributions for the upcoming year. This move is aimed at providing sustained income for its common stockholders under the managed distribution plan established by the Fund's Board of Trustees. The plan emphasizes an annual distribution rate of 10%, a promising figure for both current and prospective investors in the Fund.

Details of Upcoming Monthly Distributions

For the year 2025, the Fund intends to distribute monthly payments at a rate of 0.8333%. These distributions are based on the net asset value of the Fund, which is currently set at $7.11 per common share as of the last day of the previous year. This systematic approach underlines the Fund's commitment to delivering consistent income to its stockholders.

Declared Distribution Rates

The anticipated distribution rates for the first three months of the year are outlined as follows:

  • January: $0.0593
  • February: $0.0593
  • March: $0.0593

Each payment is essential, as it reflects the ongoing commitment of the Fund to uphold its distribution goals, ensuring stockholders are rewarded every month.

Important Dates for Shareholders

To facilitate these distributions, the following key dates are scheduled:

  • Record Date for January: January 21, 2025
  • Payable Date for January: January 31, 2025
  • Record Date for February: February 18, 2025
  • Payable Date for February: February 28, 2025
  • Record Date for March: March 18, 2025
  • Payable Date for March: March 31, 2025

Stockholders should take note of these dates to ensure they are positioned to receive their distributions without any discrepancies.

Distribution Notification Procedure

The Fund has committed to notifying its stakeholders regarding the distribution estimates. An important aspect of these notifications will be the breakdown of the composition of each distribution. This is vital for tax reporting, as it enables stockholders to understand the nature of the received distributions thoroughly.

Tax Considerations for Investors

Investors will receive a Form 1099-DIV, which outlines the actual composition of their total distributions for the year. This is essential for accurate tax reporting. Being well-informed allows investors to navigate their tax responsibilities effectively while capitalizing on the benefits of these distributions.

Understanding the Fund's Managed Distribution Plan

The managed distribution plan reflects the Fund’s forward-thinking approach to income generation in a fluctuating market. By committing to a consistent distribution strategy, the High Income Securities Fund empowers its stockholders to plan their finances better and rely on a steady cash flow, which can be vital for both current expenses and future investments.

Why Consider the High Income Securities Fund?

For investors, the High Income Securities Fund (NYSE: PCF) presents a compelling case. The monthly distributions provide not only a reliable income stream but also a signal of the Fund’s financial robustness. As such, investors looking for stable income sources may find the Fund to be an attractive option.

Frequently Asked Questions

What is the annual distribution rate for the Fund?

The Fund has determined an annual distribution rate of 10% for its common stockholders.

When will the distributions be paid out?

The monthly distributions for January, February, and March will be paid on January 31, February 28, and March 31, respectively.

How does the Fund’s managed distribution plan work?

The managed distribution plan allows the Fund to provide regular monthly payments to stockholders based on the net asset value of its common shares.

What should investors expect from the Form 1099-DIV?

The Form 1099-DIV will provide details on the actual composition of distributions and is used for tax reporting purposes.

Why is the High Income Securities Fund a good investment choice?

The Fund offers a reliable income stream through its monthly distributions, coupled with a solid management strategy, which appeals to income-focused investors.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Bidease Taps Moloco Veteran Dock Kim for Growth Role

Updated Category News Views 7

In the rough-and-tumble world of mobile advertising, cutting through the noise with real results is no easy feat. Yet Bidease finds itself riding high on a wave of growth—200% revenue increase over back-to-back years. That's no small potatoes, and now they're topping it off with a savvy hire: Dock Kim, the former revenue honcho at Moloco, is on deck as the new VP of...

Continue Reading
Unicycive Faces Legal Heat Amid Stock Tumble

Updated Category News Views 2

Unicycive Therapeutics' Rough Ride In this wild market, sometimes even the most seasoned investors get blindsided. Unicycive Therapeutics (NASDAQ: UNC) shareholders are currently caught in a storm with their stock nose-diving by 39.1% on June 30, 2026. It's like being taken to the cleaners without the decency of a warning. Failed Expectations & FDA Blues Here's the...

Continue Reading
Patrick Ta Beauty Adds New Leadership to Expand Growth

Updated Category News Views 2

Angela Simpson and Carolyne Rapp Join the Ranks In the fast-paced world of beauty, where trends shift faster than a day trader’s mood, Patrick Ta Beauty is shaking things up with some heavyweight hires. Angela Simpson steps in as Chief Marketing Officer, and Carolyne Rapp takes the reins as Vice President of Creative. Maybe it’s just me, but when a brand ropes in pros...

Continue Reading
Gala Spotlights Veterans' Mental Health Support

Updated Category News Views 11

Champions for Veterans Honored at Headstrong Gala If you ever wondered who stands in the trenches alongside veterans facing mental health battles, this year's Headstrong Gala offered a crystal-clear answer. Held on October 16 at Pier Sixty in New York City, this shiindig wasn’t just about schmoozing over canapés. It was about celebrating the grit and guts of those...

Continue Reading
DCK Reveals Versatile Battery-Powered Garden Tools in 2026

Updated Category News Views 2

Battery-Powered Revolution in Louisville The treadmill of lawn care just took a high-tech spin with DCK Tools strutting their stuff at Equip Exposition 2026. Unrolled at the Kentucky Exposition Center, the event from October 21 to 23 was brimming with their battery-powered wares that aim to take the grunt out of yard work. Game-Changing Range of Garden Tools DCK's decked...

Continue Reading
Volvo Faces Rough Q3, Plans Strategic Responses

Updated Category News Views 7

Volvo's Bumpy Ride Through Q3 2026 Volvo Cars isn't painting a pretty picture for the third quarter of 2026. Posting an operating income of SEK -3.7 billion and a negative EBIT margin sitting at -5.6%, they're definitely feeling the heat. Market shifts in China and the U.S. are squeezing them, and it shows. Crunching the Numbers Let's break this down. Revenue nose-dived...

Continue Reading
Hyperliquid Reports Q3 2026 Results with Webcast Insights

Updated Category News Views 5

Unlocking Hyperliquid’s Third Quarter Performance It's time to grab your investing gear because Hyperliquid Strategies Inc is ready to spill the beans on their Q3 2026 performance. The digital asset treasury focused on the hyperventilating HYPE token—fined-tuned to serve US and institutional investors—is broadcasting a live webcast on November 5, 2026. Mark your...

Continue Reading
BioLineRx Explores Synergy in Ovarian Cancer Treatment

Updated Category News Views 3

New Hope on the Ovarian Cancer Front Every so often, something comes along and makes you stop and think—could this be the game-changer in the making? Well, what BioLineRx Ltd. (NASDAQ: BLRX) and Hemispherian AS just dropped at the ESMO 2026 feels a bit like that silver lining for folks fighting the uphill battle against homologous recombination (HR)-proficient ovarian...

Continue Reading
Astra Security Tackles PHP2Shell Vulnerabilities Head-On

Updated Category News Views 4

Unlocking the PHP Puzzle Hot off the press, Astra Security's stepping up to the plate with some freebie tools designed to sniff out and stamp out those pesky PHP2Shell vulnerabilities—CVE-2026-109618 and CVE-2026-109619. If you're not familiar, these suckers rate a whopping 9.2 on the CVSS v4.0 scale, and that means they got the potential to let remote code execution...

Continue Reading
Full-Life's FL-020 Shows Promise for Prostate Cancer

Updated Category News Views 4

Breaking New Ground in Prostate Cancer Treatment You know, it’s not every day you stumble across news in the medical field that perks up the ears of investors, but let me tell ya, Full-Life Technologies' latest data drop has certainly caught my attention. If there’s even a smidge of truth in these findings, we might have a game-changer on our hands in the realm of...

Continue Reading

Top 5 Most Recently Viewed Articles

D.C. Bar Celebrates Top Workplace Recognition for 2025

Updated Category News Views 150

D.C. Bar Celebrates Top Workplace Recognition for 2025 The D.C. Bar is thrilled to share that it has earned a spot on the prestigious list of Top Workplaces for 2025, as awarded by the Washington Post. This acknowledgment highlights organizations that excel in employee satisfaction and engagement in the greater Washington, D.C. area. Robert Spagnoletti, the Chief...

Continue Reading
Elsevier Develops Unique AI Evaluation Framework for Healthcare

Updated Category News Views 492

Elsevier Establishes Innovative Evaluation Framework for AI Tools Elsevier, a front-runner in medical information and analytics, has introduced a pioneering evaluation framework aimed at assessing the efficacy and safety of generative AI clinical decision support tools. This significant advancement is a part of Elsevier Health's AI solutions portfolio, including the...

Continue Reading
Ken Paxton's Lawsuit Challenges Tylenol Safety Claims

Updated Category News Views 218

Overview of Legal Action Against Tylenol Texas Attorney General Ken Paxton has taken a bold step by filing a lawsuit against Johnson & Johnson (NYSE: JNJ) and Kenvue Inc (NYSE: KVUE), accusing both companies of misleading pregnant women regarding the safety of Tylenol. Despite extensive evidence hinting at a connection between acetaminophen, the active ingredient in...

Continue Reading
Investors Take Note: Encompass Health Faces Legal Scrutiny Ahead

Updated Category News Views 184

Understanding the Legal Situation Surrounding Encompass Health The Rosen Law Firm, recognized globally for advocating investor rights, has initiated an inquiry into potential claims concerning Encompass Health Corporation (NYSE: EHC). This investigation stems from serious allegations suggesting that the company may have provided materially misleading information to its...

Continue Reading
Myrtle.ai Enhances ML Inference with Microsecond Latencies

Updated Category News Views 126

Myrtle.ai Unveils VOLLO for Ultra-Low Latency Machine Learning Myrtle.ai, a trailblazer in the field of machine learning (ML) acceleration, is making significant strides with its latest development. The company has introduced support for the VOLLO inference accelerator on the NT400D1x series of SmartNICs from Napatech. This innovation is poised to redefine ML inference...

Continue Reading